Read by QxMD icon Read

implanon reasons for removal

Khungelwa Patricia Mrwebi, Daniel Ter Goon, Eyitayo Omolara Owolabi, Oladele Vincent Adeniyi, Eunice Seekoe, Anthony Idowu Ajayi
Early discontinuation of implanon, a long-acting, reversible contraceptive among reproductive age women in South Africa is a serious public health concern. The aim of this study was to examine the reasons for discontinuation of implanon among its previous users. This descriptive cross-sectional study involved 188 consecutively selected participants in two large family planning clinics in Buffalo Metropolitan Municipality, East London, South Africa. Descriptive statistics was conducted using SPSS version 22...
March 2018: African Journal of Reproductive Health
D Pillay, C Morroni, M Pleaner, O Adeogba, M Chersich, N Naidoo, S Mullick, H Rees
Background. Implanon NXT, a long-acting subdermal contraceptive implant, was introduced in South Africa (SA) in early 2014 as part of an expanded contraceptive method mix. After initial high levels of uptake, reports emerged of frequent early removals and declines in use. Monitoring of progress and challenges in implant service delivery could identify aspects of the programme that require strengthening. Objectives. To assess data management and record keeping within implant services at primary care facilities...
October 1, 2017: South African Medical Journal, Suid-Afrikaanse Tydskrif Vir Geneeskunde
O Adeagbo, S Mullick, D Pillay, M Chersich, C Morroni, N Naidoo, M Pleaner, H Rees
Background. The South African (SA) government introduced Implanon NXT, a long-acting subdermal contraceptive implant, in 2014 to expand contraceptive choice. Following an initial high uptake, its use declined considerably amid reports of early removals and frequent side-effects. We examine providers’ perceptions of training and attitudes towards Implanon NXT, as well as their views on the causes of early removals and the impact on the implant service. Objective. To assess healthcare providers’ perceptions and attitudes towards implant services in SA...
October 1, 2017: South African Medical Journal, Suid-Afrikaanse Tydskrif Vir Geneeskunde
D Pillay, Matthew Chersich, C Morroni, M Pleaner, O Adeagbo, N Naidoo, S Mullick, H Rees
Background. Implanon NXT, a long-acting reversible contraceptive, was introduced in South Africa (SA) in early 2014, aiming to expand the method mix and increase its effectiveness. Initial uptake was high, but has since declined considerably. In these early years after the implant’s introduction, it is important to identify reasons for the decline, and remedy gaps in services. Objectives. To determine periods of use, reasons for the use and early removal of the implant Implanon NXT. Methods. In 2016, we recruited 152 women from six clinics in the City of Johannesburg, and six in North West Province, SA...
October 1, 2017: South African Medical Journal, Suid-Afrikaanse Tydskrif Vir Geneeskunde
Kim C Dobromilsky, Penny L Allen, Stephen H Raymond, Bhavna Maindiratta
BACKGROUND: Etonogestrel (ENG) implants (Implanon(®)/Nexplanon(®)/Implanon NXT(®)) are employed as contraception in early postpartum patients. Follow-up is often not conducted by the hospital prescriber. Little is known about duration of lochia, in a modern setting, and even less is known about the effect of ENG implants on lochia. AIMS: To determine if early postpartum (pre-discharge) insertion of Implanon for contraception was associated with a significant difference in duration of lochia...
July 2016: Journal of Family Planning and Reproductive Health Care
Anna Maria Teunissen, Bernd Grimm, Frans J M E Roumen
OBJECTIVES To investigate the continuation rates of the etonogestrel subdermal contraceptive implant among well-informed women, and the reasons for early discontinuation. STUDY DESIGN Retrospective consecutive cohort design. METHODS Women who had the implant inserted between 1 January 2006 and 1 January 2010 at the Atrium Medical Centre, the Netherlands were followed up for at least three years. The dates of insertion and removal were recorded, as were the reasons for removal. Statistical analysis was performed using the independent samples t-test and the Pearson alpha correlation test...
February 2014: European Journal of Contraception & Reproductive Health Care
Pushpa Bhatia, Sangita Nangia, Shivani Aggarwal, Chitra Tewari
OBJECTIVES: Study was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon. METHODS: Volunteers having regular menstruation, requiring spacing formed study population. Implanon was inserted within 5 days of LMP or concurrent with MTP. Woman was asked to record bleeding pattern, side effects. Implanon duration was 3 years but Implanon was removed before, if patient wanted pregnancy/for side effects. Subjects who did not adopt family planning method after removal were followed up for return of ovulation and pregnancy...
August 2011: Journal of Obstetrics and Gynaecology of India
Caroline Harvey, Charrlotte Seib, Jayne Lucke
BACKGROUND: This study examined demographic profile, continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia. STUDY DESIGN: A retrospective chart audit of 976 women who attended for implant insertion over a 3-year period between May 2001 and May 2004. RESULTS: Continuation rates showed that at 6 months after insertion, 94% of women continued, 74% continued at 1 year and 50% continued at 2 years...
December 2009: Contraception
Renee C Wong, Robin J Bell, Kalyani Thunuguntla, Kathleen McNamee, Beverley Vollenhoven
BACKGROUND: The study was conducted to perform a direct comparison of the satisfaction of intrauterine device (IUD) users and Implanon users after 6 months. STUDY DESIGN: Women were recruited to this study in the contraception clinics of Southern Health and Family Planning Victoria. Each woman completed a questionnaire at the time of starting her contraception with either an IUD or Implanon. Women were sent a follow-up questionnaire after 6 months to assess their satisfaction with their chosen method of contraception...
November 2009: Contraception
H Prosch, R M Walter, V Westermayer, G H Mostbeck
PURPOSE: Implanon is a rod-shaped hormone implant which leads to reliable contraception. The rod is implanted in the subcutis of the upper arm and is usually removed easily after its effective period. In the scenario where the rod is not palpable, the removal of the rod can be difficult or impossible. The purpose of this study was to evaluate the reliability of US in locating non-palpable Implanon implants and to investigate the optimal technical parameters for determining the location...
December 2008: Ultraschall in der Medizin
Manopchai Thamkhantho, Supanee Jivasak-Apimas, Surasak Angsuwathana, Gessuda Chiravacharadej, Jarataporn Intawong
BACKGROUND: The single-rod Implantable contraceptive method, called 'Implanon', has been introduced for use in Thailand since the 1990s. The outstanding attribute was that it requires only a few minutes for insertion and removal as it has only one capsule. The single-rod implant was used in women at Siriraj Hospital in 2006. The present study looked at characteristics of women, complications of insertion and removal, menstrual events that occurred to women during one year of use and reason for removal of the method...
June 2008: Journal of the Medical Association of Thailand, Chotmaihet Thangphaet
Paul D Blumenthal, Kristina Gemzell-Danielsson, Maya Marintcheva-Petrova
OBJECTIVES: To evaluate the tolerability and clinical safety of the subdermal, long-acting hormonal contraceptive Implanon. METHODS: This integrated safety analysis included 11 international studies concerning Implanon (68 mg etonogestrel) of which 10 had a duration of at least two years. Assessments included reports of adverse events (AEs), reasons and rates of discontinuation, insertion/removal complications, and the condition of the implant site. Metabolic and coagulation parameters are briefly discussed to fully describe the clinical safety profile...
June 2008: European Journal of Contraception & Reproductive Health Care
Eric Vidin, Olivier Garbin, Brice Rodriguez, Romain Favre, Karima Bettahar-Lebugle
OBJECTIVES: We describe removal procedures for etonogestrel contraceptive implants in the operating theater. In addition, we discuss the management of removal of contraceptive implants that are difficult to palpate or are impalpable. DESIGN: We conducted a retrospective single-center case series analysis of Implanon removals conducted at a university hospital between January 2002 and April 2005. MATERIALS AND METHODS: We analyzed case notes for 28 patients who had their contraceptive implant removed in the operating theater...
July 2007: Contraception
Anjali Agrawal, Christine Robinson
OBJECTIVES: Implanon was introduced in the UK in September 1999. We present here the results of our first 106 Implanon insertions, performed over a period of 18 months. The aims of the study were to study the clinical and demographic profile of Implanon users, to assess the continuation rates of Implanon in the local population, and to identify the reasons for removal. METHODS: This was a case note-based study in which the data were transferred to a standardised pre-tested proforma...
October 2005: Journal of Family Planning and Reproductive Health Care
Edith Weisberg, Ian Fraser
AIM: To describe Australian women's experiences and acceptability of etonogestrel releasing subdermal contraceptive implant (Implanon). METHODS: Six hundred and fifty-one women were recruited at the time of implant insertion and asked to complete a self administered questionnaire immediately after insertion and at 3, 6 and 12 months after insertion. RESULTS: Four hundred and seventy-five women aged 15-50 years responded at least once. Forty-one women had the device removed before 3 months, 48 between 3-6 months, and 75 between 6-12 months...
August 2005: Australian Family Physician
J Bitzer, S Tschudin, J Alder
DESIGN: A multicenter, retrospective study of the single-rod contraceptive implant, Implanon (NV Organon, Oss, The Netherlands), was carried out in Switzerland in 1183 women. METHODS: Assessments included duration of use, bleeding pattern, side-effects and subjective acceptability and satisfaction with the method. RESULTS: A total of 991 women (84%) had at least one follow-up visit and 306 (26%) had two visits with a mean duration between insertion and follow-up of 224 days (7...
December 2004: European Journal of Contraception & Reproductive Health Care
Solomon B Yisa, Angela A Okenwa, Roy P Husemeyer
BACKGROUND: Endometriosis is one of the commonest benign gynaecological disorders and has a peak incidence between 30 and 45 years of age. Treatment options are medical or surgical, depending on the location and extent of the disease and the woman's childbearing aspirations or need for contraception. Over the past five decades several formulations of progestogen have been used to treat endometriosis. METHODS: Our study was not planned research but a series of case studies of women with severe symptoms of endometriosis treated in an innovative way with a new long-acting progestogen contraceptive system (etonogestrel subdermal implant) which could reasonably have been expected to have a favourable effect on their disease and its symptoms...
January 2005: Journal of Family Planning and Reproductive Health Care
F Sergent, C Clamageran, A-M Bastard, E Verspyck, L Marpeau
OBJECTIVES: To estimate the exact satisfaction of women toward Implanon, the sole contraceptive implant available in France. To clarify the indications of this type of contraception. MATERIAL AND METHOD: Among a population of 182 women with Implanon" inserted in a same family planning service between May 22, 2001 and February 14, 2003, 108 women agreed to answer a questionnaire of satisfaction. Implants were inserted in one third of cases after childbirth, in another third after abortion...
September 2004: Journal de Gynécologie, Obstétrique et Biologie de la Reproduction
S Reuter, A Smith
OBJECTIVE: Implanon (NV Organon, Oss, The Netherlands) was released in the United Kingdom towards the end of 1999. This survey elicited the experiences of women who had the new implant inserted in three family planning services in North Trent, UK during the first year after its introduction. METHOD: A previously piloted questionnaire was sent to all Implanon users who had the devices fitted in the three services between December 1999 and December 2000. Returned questionnaires were analyzed...
March 2003: European Journal of Contraception & Reproductive Health Care
Amanda Smith, Simone Reuter
AIMS: The aims of the study were three-fold, namely to assess continuation rates with Implanon fitted in clients from three contraception and sexual health services; to identify factors associated with early removal of Implanon; and to assess clinician compliance with recommended practice in counselling and insertion. METHODS: Retrospective review of client records, and comparison with audit criteria. Postal survey. MAIN FINDINGS: One hundred and ninety women had Implanon inserted in the study period...
October 2002: Journal of Family Planning and Reproductive Health Care
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"